Many have built successful practices around facial rejuvenation, skin tightening, and injectable treatments, and for good reason. But the market is moving.

Clinics that rely solely on facial treatments are now overlooking one of the most accessible routes to meaningful revenue growth.

A New Category of Patient Demand

Perhaps the most significant driver of body treatment demand in 2025 and 2026 has been the rapid adoption of GLP-1 weight loss medications such as semaglutide and tirzepatide.

According to research published in BMC Medicine, around 1.6 million UK individuals used these medications to support weight loss between early 2024 and early 2025. An additional 3.3 million expressed interest in starting treatment within the next year. The patient pipeline is vast and continues to expand.

Weight Loss Is Only Half the Story

The aesthetic consequences of rapid weight loss are becoming difficult to ignore. A review published in the Journal of Cosmetic Dermatology notes that GLP-1-driven weight loss often results in skin that no longer conforms to the body’s new contours.

These patients look thinner, but they don’t necessarily look toned or feel confident about their shape. This creates a patient who is actively motivated and looking for a non-surgical solution to complete their transformation.

For clinics that can offer targeted body tightening and muscle toning, this is a new demographic walking through the door. The demand isn’t going away.

The Revenue Case for Body Treatments

There is strong commercial logic for adding body treatments to your menu. Body services naturally lend themselves to multiple areas of treatment. A patient who comes in for abdominal toning may also want thigh contouring, glute lifting, or arm tightening. Because of this, body treatments are more easily packaged into treatment courses and have a high average transaction value.

Course-Based Revenue and Operational Efficiency

Body sculpting and toning courses lasting six to eight sessions are common in the category, resulting in predictable, recurring revenue over several weeks. Compared to one-off facial treatments, a body treatment programme often represents a significantly larger per-patient spend. When you factor in the potential for maintenance sessions and cross-referrals into existing facial services, the lifetime value of a body treatment patient can be substantial.

There’s also a practical efficiency benefit. Modern body sculpting platforms like BodyStim are designed to streamline treatment delivery. Built-in pad-placement guidance and real-time thermal sensors enable precise setup and controlled energy delivery, decreasing the complexity of each session.

With dual-subject simultaneous treatment capability, a single device can treat two patients at once, meaning higher revenue per hour from a single piece of equipment compared to procedures that can only serve one patient at a time.

The Timing Advantage

Body treatments in the UK aesthetic market are still in a growth phase. Unlike injectables or skin rejuvenation, where competition is fierce and patient loyalty needs to be earned, body sculpting and toning is a category where many clinics have not yet established a strong position. For facial-focused practices that move now, there is a genuine first-mover advantage in their local market.

Establishing body treatments as part of your clinic’s identity takes time. Patients need to see results from other clients and build confidence in the treatment. Clinics that begin to establish this reputation now will be significantly better positioned when body treatment demand, driven by GLP-1 adoption and broader consumer trends, reaches new heights.

Why Clinics Hesitate When Acquiring New Devices

The most common objection from facial-focused clinics is that body treatments feel like a separate business. The patient demographics seem different, the marketing feels unfamiliar, and the technology requires a new investment. These concerns are understandable, but they are increasingly outdated.

Why the Barriers Are Lower Than You Think

The reality is that most clinics already have the patient base for body treatments. Patients who trust you with their facial aesthetics are ideal candidates for body services. They already have a relationship with your clinic, they are comfortable spending on non-surgical treatments, and many of them are privately wondering whether you offer something for the areas they see in the mirror from the neck down.

Introducing body treatments doesn’t mean building a new audience. It means serving the existing one more completely.

Modern devices fit easily into standard clinic environments and can be operated by existing team members with straightforward onboarding. When acquiring a new device from us, we offer comprehensive training to help you and your team get up to speed as quickly as possible.

While it does require investment, the return timeline for a well-positioned body sculpting device is typically faster than many clinics expect, particularly when treatment courses are sold upfront.

What to Look for in a Body Treatment Platform

Not all body devices are created equal, and clinics entering this space should be discerning about the technology they invest in. The most commercially successful body treatment platforms tend to share a few key characteristics.

Versatility, Efficiency, and Clinical Credibility

A device that only addresses one concern limits your treatment menu and your ability to respond to what patients actually want. The strongest platforms combine muscle stimulation with skin tightening, allowing clinics to address tone, definition, and laxity in a single treatment protocol. This dual action is important for patients losing weight and experiencing muscle loss and skin laxity simultaneously.

Devices that facilitate multi-area or dual-patient treatment allow clinics to maximise throughput without sacrificing results. The ability to treat several body zones in a single session has a direct impact on revenue per hour.

Third is clinical credibility. In an increasingly educated market, patients are doing their research before they book. A body treatment device backed by visible clinical results and a clear mechanism of action provides both the clinic and the patient confidence in the investment.

Where BodyStim Fits

For clinics evaluating their options, BodyStim by Imperium is worth a close look. It combines RF diatermocontraction (a controlled radiofrequency signal that triggers both deep heating and muscle contraction) with neuromuscular stimulation, delivering both skin tightening and muscle toning through a single platform.

Three treatment modes (Thermosculpt™, biQuad+™, and Hybrid) allow practitioners to customise protocols to meet particular patient goals, including deep muscle activation, targeted contour refinement, or a combination of both.

Built for Clinic Profitability

BodyStim supports dual-patient treatment, meaning two people can be treated simultaneously. For busy clinics looking to maximise the commercial return on a single device, this is a significant operational advantage.

Importantly, BodyStim aligns with the specific clinical needs of patients who have recently lost significant weight. Its combination of muscle toning and skin tightening makes it well-suited to the growing number of post-weight-loss patients now seeking non-invasive body treatments.

Take the Next Step

If you’re thinking about whether body treatments are a good fit for your clinic, we’d love to talk.

We work with clinics across the UK to identify the right technology for their goals and growth stage. Whether you’re starting from scratch with body services or looking to upgrade from a basic platform, our team can help you model the revenue potential and find the right fit.

Get in touch with our team to book a BodyStim demonstration or discuss how body treatments could fit into your clinic’s growth strategy.

The post The Body Treatment Opportunity: Why Facial-Only Clinics Are Leaving Revenue on the Table appeared first on Aesthetic Medical Partnership.

By combining key biomarkers with individual patient risk factors, the system helps clinicians move beyond visual assessment alone when faced with uncertainty. Alongside the clinical insight, the session also covers the practical considerations of introducing structured oral cancer screening into a modern dental practice – including how it can fit within the patient journey and support the development of additional clinical services.

The post Rapid Chairside Oral Cancer Screening | Prof. Bob Khanna appeared first on Aesthetic Medical Partnership.

Led by Dr Sary Kadar, Medical Director of Estar Medical and a recognised expert in autologous regenerative therapies, this webinar combines clinical insight with hands-on experience. With a strong focus on PRP applications across dermatology, skin rejuvenation and hair restoration, it offers valuable guidance for practitioners looking to deliver more predictable, natural-looking results.

The post Cellenis PRP for Hair Restoration Webinar | Dr Sary Kadar appeared first on Aesthetic Medical Partnership.

Developed by Solta Medical (now part of Bausch Health), the Fraxel Dual set the benchmark for non-ablative dual-wavelength treatment when it launched over a decade ago.

It remains a trusted, widely recognised platform in clinics around the world.

But the device landscape has changed. Clinic economics are tighter, and patient expectations are higher. A growing number of practitioners require a resurfacing solution that aligns with modern workflows without the overhead of a legacy console system. That is the gap MultiFrax was built to fill.

This article presents a straightforward comparison of MultiFrax and Fraxel Dual across the key areas that matter most to clinic owners and practitioners: wavelength capability, portability, cost of ownership, clinical flexibility, and day-to-day usability.

The Shared Foundation: 1550nm and 1927nm

Both devices are built around the same dual-wavelength principle that has become the gold standard in non-ablative fractional resurfacing.

The 1550nm erbium fibre wavelength penetrates deeper into the dermis, addressing textural issues such as acne scars, fine lines, wrinkles, stretch marks, and overall skin laxity. The 1927nm thulium wavelength works more superficially, targeting pigmentation, sun damage, dyschromia, and early melasma.

Published clinical evidence supports the use of both wavelengths in combination for more complete results than either wavelength alone. A multi-centre study published in the Journal of Drugs in Dermatology demonstrated moderate improvement in photodamage severity with combined 1550/1927nm treatment, alongside excellent tolerability and no major adverse events.

In this respect, MultiFrax and the Fraxel Dual operate on the same proven clinical foundation. The differences lie in how each platform delivers those wavelengths, and what that means for your clinic.

Where MultiFrax Differs from the Fraxel Dual

Simultaneous Dual-Wavelength Delivery

The Fraxel Dual allows practitioners to choose either the 1550nm or 1927nm wavelength per pass, switching between them during a session. MultiFrax takes this a step further with its patented SimulScan™ technology, which fires both wavelengths simultaneously in a single pass. This allows practitioners to address both deep textural issues and surface pigmentation at the same time. This eliminates the need for repeated sequential passes over the treatment area.

The clinical advantage is efficiency: fewer passes, shorter treatment times, and a lower cumulative thermal load on surrounding tissue. For patients, this can lead to improved comfort and a streamlined session. For clinics, this means the ability to treat more patients each day.

True Portability

The Fraxel Dual is a console-based system. It requires a dedicated room, a power outlet, and a fibre-optic cable connecting the base unit to the handpiece. This is the standard form factor for most fractional lasers on the market.

MultiFrax reimagines this completely. The laser source sits inside a lightweight handpiece powered by a rechargeable lithium battery that provides over four hours of continuous use.

There is no console, no wall cable, and no fibre-optic delivery system. Practitioners clip in the battery, attach the handpiece, and are treatment-ready in seconds in any room, at any location.

This portability also provides a technical benefit. Because the laser source is placed within millimetres of the skin rather than metres away via a fibre-optic connection, the beam arrives with less dispersion. The result is a finer, more precise 150μm micro-column, which can contribute to improved comfort during treatment and more controlled thermal zones.

Cost of Ownership and Per-Treatment Economics

This is where the comparison becomes particularly compelling for clinic owners. Traditional console-based fractional lasers, such as the Fraxel Dual, have considerable costs. These can include expensive initial purchase or lease prices, continuous service contracts, consumable tips, and the overhead involved with dedicating a room to a large device.

MultiFrax offers up to 90% lower cost per use than competing platforms. Each multi-treatment tip delivers approximately two million shots, which is enough for seven full-face treatments, five décolletage sessions, and ten hand treatments.

The device requires no external cooling system, no fibre-optic replacements, and no annual calibration. For clinics wanting to offer fractional resurfacing without the financial burden of a traditional system, the economics are significantly more favourable.

Precision and Operator Guidance

The Fraxel Dual uses an intelligent optical tracking system that adjusts pulse delivery to hand speed, distributing treatment zones evenly across the skin. It is a successful approach that has helped standardise treatment quality for years.

MultiFrax offers a comparable level of treatment control through its SmartSense™ real-time feedback system, which visually signals the operator when handpiece speed and contact quality are optimal. The device also provides adjustable scan widths (2-14mm) and flexible micro-column spacing (0.5-2mm), allowing practitioners to tailor treatment density precisely to each patient’s phototype and clinical indication.

What About the Fraxel FTX?

In April 2025, Bausch Health launched the Fraxel FTX, the next-generation successor to the Fraxel Dual. It provides genuine improvements to the Fraxel Dual:

• A handpiece with a 20% reduction in weight and size, and integrated cooling.
• An updated AccuTRAC tracking system.
• A modernised console interface.

The FTX remains a console-based system that requires a dedicated room, fibre-optic delivery, and the associated infrastructure. There is no indication that FTX has implemented simultaneous dual-wavelength firing.

This is the main distinction. The FTX is a refinement of the existing Fraxel model. Where the FTX has made the console experience better, MultiFrax has removed the console entirely.

The Fraxel FTX is a strong device from a reputable brand. But for practitioners whose priorities centre on portability, treatment efficiency, and reduced operating costs, MultiFrax offers a unique set of advantages that the FTX update does not address.

Who Should Consider MultiFrax?

MultiFrax is designed for practitioners and clinic owners who want the clinical capability of a premium fractional resurfacing system without the traditional barriers to entry.

It is particularly ideal for:

• Clinics that want to add fractional laser resurfacing to their menu without the need for a large console and dedicated room.
• Practitioners who want to treat across multiple locations and need a system that travels with them.
• Established laser clinics seeking to lower their cost per treatment while maintaining or improving clinical results.
• Clinics seeking a long-term investment in a growing device category.

It is not a matter of whether the Fraxel Dual is a good device. It is.

It has an excellent clinical track record and strong brand recognition with patients.

The question is whether, in 2026, the traditional console model remains the best option for your specific clinic environment, patient base, and growth plans.

The Bottom Line

The Fraxel Dual has established a reputation as a category-defining device. It introduced millions of patients and practitioners to the benefits of dual-wavelength non-ablative resurfacing, and it remains a respected name in the field.

MultiFrax is built on the same proven wavelength foundation, but delivers it in a fundamentally different way. It is portable, fires both wavelengths simultaneously, costs significantly less to run, and is designed for the way modern clinics actually work.

It offers the clinical depth of a full-sized system with the flexibility, accessibility, and economics that today’s practitioners increasingly demand.

For UK clinics considering fractional resurfacing, whether for the first time or as a replacement for an existing platform, MultiFrax represents a compelling alternative worth serious consideration.

Ready to See MultiFrax in Action?

Book a hands-on demonstration with the AMP team. Fill out a contact form or call 01727 482 432 to arrange your demo.

The post MultiFrax vs Fraxel Dual: How Do The Lasers Compare? appeared first on Aesthetic Medical Partnership.

Moving beyond surface-level trends, the session focuses on the biological foundations that underpin treatment outcomes in both hair and skin restoration. Dr Rob explains how matrix conditioning directly impacts cell communication, tissue response and ultimately the consistency of clinical results.

Drawing on current science and real-world clinical experience, the webinar introduces the concept of structured regenerative protocols designed to support signalling pathways, optimise recovery and improve treatment predictability.

The discussion also examines the role of plant-derived exosome technologies, including EXO|E Skin Revitalising Complex and DE|RIVE Hair Wellness System, and how these can be integrated into everyday practice to support matrix health and enhance regenerative performance.

A valuable session for practitioners looking to deepen their understanding of regenerative medicine and apply it more effectively within clinical practice.

…………………………..

Dr Rob King is Vice President of Sales at Aesthetic Management Partners and a medically trained physician with over a decade of experience in aesthetic and regenerative medicine. He holds a Doctor of Medicine from the University of Illinois, completed training in General Surgery, and earned a degree in Molecular Physiology with a minor in Biochemistry. His background in cellular science and clinical medicine underpins his evidence-led approach to regenerative protocols. Dr King also serves in the Army National Guard with over 20 years of distinguished service.

The post Why the Matrix Matters: Understanding Secretome Signalling in Hair and Skin Restoration with EXO|E and DE|RIVE appeared first on Aesthetic Medical Partnership.

Millions are now benefiting from appetite suppression and improved insulin sensitivity, and aesthetic clinics across the UK are seeing the results in real time.

But with this transformation comes a new clinical responsibility. Patients are experiencing tremendous physical change, but many still have to deal with unanticipated aesthetic consequences.

The opportunity for forward-thinking clinics? To evolve in tandem with this shift and provide structured, regenerative solutions that support the full transformation journey.

The Rise of the “GLP-1 Patient”

Rapid weight reduction affects more than adipose tissue (fat tissue). It affects muscle mass, hair growth cycles, collagen integrity, and skin thickness. The post-GLP-1 patient often appears healthier and thinner, but they may also experience facial hollowing, loose skin, and tone loss, which can create a discrepancy between how they feel and how they look.

Common concerns include facial volume loss and contour changes, cutaneous laxity across the arms, abdomen, thighs and neck, reduction in muscle tone due to lean mass loss, and hair thinning brought on by metabolic shifts. These issues are layered and interconnected, and they cannot be solved with a single treatment approach.

Facial Laxity & Structural Change: The Role of FaceStim by Jovena®

Post-weight-loss facial ageing is not simply about wrinkles; it is about structural support. GLP-1 patients who have lost weight quickly are more likely to experience neck laxity, jawline softening, and mid-face flattening. Clinics require technology that refines surface texture and stimulates collagen deeply.

FaceStim by Jovena® combines radio frequency diathermic contraction (controlled heat energy to stimulate collagen and tighten skin) with fractional plasma technology (creates micro-treatment zones on the skin surface to resurface texture and support renewal). This addresses both laxity and dermal quality in one intelligent platform.

Designed for face and neck treatments, it offers tightening, lifting and resurfacing with little downtime, allowing clinics to provide rejuvenation without adding surgical complexity to their menu.

Muscle Tone & Contour Integrity: Why Bodystim® by Imperium Matters

Lean mass loss is one of the least discussed but most impactful consequences of accelerated weight reduction. Once muscle fibres have reduced, even those who continue their gym routines may find it difficult to regain tone in their thighs, glutes, and abdomen.

Bodystim® by Imperium uses advanced neuromuscular electrical stimulation to retrain and rebuild muscle fibres, helping restore definition and strength in important anatomical areas. Bodystim is positioned as a link between functional restoration, body sculpting, and cosmetic treatment because of its integrated radiofrequency, which also promotes collagen formation and skin tightening.

Hair & Scalp Health: Addressing the Hidden Concern

Hair thinning is often emotionally significant for patients who have otherwise achieved their weight goals. Rapid metabolic shifts can disrupt the hair growth cycle, resulting in quick and unexpected shedding.

DE|RIVE Exosomes offer a clinically proven hair rejuvenation method that targets both scalp and follicular health with peptides and growth factors. With an in-clinic and at-home protocol, DE|RIVE enables clinics to provide patient care beyond procedural appointments, creating a structured pathway for long-term scalp optimisation.

From Weight Loss to Aesthetic Optimisation

The GLP-1 era signals more than a trend; it represents a long-term change in patient demographics. In the wake of rapid physiological change, aesthetic medicine must now help people restore balance, proportion, and tissue integrity in addition to making them look younger.

This calls for a multi-modality strategy. By integrating FaceStim by Jovena®, Bodystim® by Imperium and DE|RIVE Exosomes into a cohesive protocol, clinics can position themselves at the forefront of regenerative aesthetics, offering patients full transformation, not fragmented solutions.

Talk to us about any of our devices or biologics if you’re interested to learn more.

Why This Matters for Your Clinic

Patients are becoming more knowledgeable, experience-focused, and results-oriented. They are looking for strategies rather than just cures. Clinics will stand out in a competitive market if they can reliably help post-GLP-1 patients with muscle restoration, skin tightening, and scalp rejuvenation.

We combine evidence-based technologies and in-clinic support to help you build future-ready treatment pathways. Through Jovena, Bodystim and DE|RIVE, we equip your practice to meet the evolving expectations of patients who are not only shedding pounds but redefining how they want to look and feel.

The post Reimagining Aesthetic Medicine in the Era of GLP-1s appeared first on Aesthetic Medical Partnership.

Clinic owners are focusing on building a credible regenerative offering, so they need clarity on what’s worth adding to their menu, the supporting evidence, and how these modalities work together in practice.

What Does “Regenerative Aesthetics” Actually Mean?

Regenerative aesthetics refers to treatments that support or stimulate the body’s own repair and renewal processes. The aim is to encourage the skin to act like younger skin. This means improving your skin’s collagen and elastin production, improving its structural integrity, and remodelling over time.

This is different from traditional injectable fillers or superficial skin treatments. When chosen carefully and used appropriately, regenerative approaches can produce visible, durable improvements in skin quality, texture, and appearance.

Plant-Derived Extracellular Nanoparticles

The term “exosome” has become common in aesthetics marketing, but precision matters here.

Exosomes are small extracellular vesicles released by cells that act as biological messengers, carrying signals involved in repair, immune response, and regeneration. Human-derived exosomes remain tightly regulated in the UK, and products claiming to contain them carry significant compliance considerations.

The more accessible and clinically interesting category is plant-derived extracellular nanoparticles (PDENs), sometimes described as the plant equivalent of human exosomes.

PDENs are nano-sized vesicles produced during processes of plant cell activation. They carry a naturally occurring payload of growth factors, peptides, amino acids, proteins, and liposomes that can interact with human skin cells and support regeneration through biomimetic signalling.

Research into PDENs is relatively early but growing. Peer-reviewed studies and reviews of plant-derived extracellular vesicles, often described as exosome-like nanovesicles, suggest anti-inflammatory activity and potential roles in tissue repair in preclinical settings. This includes dermatology-focused discussion in the Journal of Nanobiotechnology, a chronic wound healing review in the International Journal of Nanomedicine, mechanistic work linking vesicles to angiogenesis in ACS Applied Materials & Interfaces, and earlier anti-inflammatory research published in Biomaterials. They work topically or via assisted transdermal delivery. The mechanism is one of supporting the skin’s natural signalling environment, not introducing cellular material.

EXO|E is AMP’s professional skin revitalising complex, built around plant stem cell technology and a PDEN-containing formulation called CF-a1. It’s chemical-free, water-based, and designed for use alongside aesthetic procedures.

The three-step protocol covers pre-treatment preparation (D|TOX), in-clinic application (EXO|E concentrate), and post-procedure recovery (RE|PAIR). This gives clinics a structured, repeatable patient journey that supports outcomes and reduces downtime.

PRP in Aesthetics

Platelet-Rich Plasma is one of the more established biologic treatments in aesthetics. A small volume of the patient’s blood is centrifuged to isolate a platelet-rich fraction, which is then reintroduced to the treatment area. Platelets carry growth factors, including PDGF, TGF-beta, and VEGF, that support tissue repair, collagen synthesis, and new blood vessel formation.

The evidence base is most consistent in three areas: skin quality improvement, hair restoration, and adjunctive use alongside device-based treatments. PRP is not, in the main, a volumising treatment, and managing patient expectations on this point matters.

Consistency is one of the more significant clinical challenges with PRP. Platelet yield varies between patients and between systems. The preparation method, including centrifuge speed, time, tube type, and separation technology, directly affects the output. The system you choose is as clinically significant as the protocol you follow.

Cellenis PRP addresses this through a specialist gel-separator tube that is intended to minimise red blood cell contamination in the PRP fraction; the manufacturer describes this as almost complete RBC elimination.” Virtually all red blood cells are removed, and inflammatory white blood cells are significantly reduced in a single centrifuge spin. The simplified three-step workflow (collect, extract, treat) supports consistency across practitioners and patient visits, which matters for both clinical outcomes and patient confidence.

“Using a gel-separator tube, the system is intended to minimise red blood cell contamination in the PRP fraction; the manufacturer describes this as almost complete RBC elimination.”

https://www.cellenis.com/cellenis-prp/

Cellenis PRP is most commonly used in UK clinics for facial skin quality protocols, scalp and hair restoration programmes, neck and décolletage treatments.

Autologous Biofiller

Autologous biofiller, sometimes called platelet-rich dermafiller, represents a natural development of PRP technology. Rather than using the platelet-rich plasma fraction alone, this approach processes the platelet-poor plasma (PPP) component to create a gel-like injectable that provides immediate volumising alongside long-term regenerative benefit.

Cellenis DermaFiller works by heating the PPP fraction to restructure its albumin proteins, producing a natural injectable gel derived entirely from the patient’s own blood. The result is dual-action: an immediate soft volumising effect (results typically last three to six months) combined with ongoing stimulation of collagen, fibrin, and elastin production beneath the surface.

Because Cellenis DermaFiller is autologous, there is no risk of allergic reaction or immune response. It is naturally biocompatible, and the regenerative benefit continues after the initial volumising effect diminishes.

Cellenis DermaFiller is not a direct replacement for hyaluronic acid fillers. It produces a softer, more diffuse effect and suits patients looking for natural-looking improvement.

Combining Biologics with Energy-Based Devices

The relationship between biologics and energy-based devices is not just additive. In many cases, it is genuinely synergistic. Devices that create controlled micro-injury or thermal remodelling generate a healing cascade in the skin. Introducing biologics at the right point in that cascade can amplify the response, improve outcomes, and shorten recovery.

There are four combination protocols clinics can apply regularly:

1. Pre-treatment skin preparation

EXO|E’s D|TOX step is designed for this purpose and is applied by the patient for 7 days before treatment to reduce baseline inflammation and improve skin receptivity.

2. Concurrent application

Following microneedling, RF microneedling, or fractional treatment, applying EXO|E’s in-clinic concentrate allows active components to reach the dermis more effectively than through intact skin.

The ULTRA+ device from AMP is specifically designed to work alongside EXO|E, combining ultrasound, radiofrequency, and EMS with structured serum delivery as part of a controlled facial or scalp protocol. This extends the clinical value of a device treatment into the healing window. The RE|PAIR step within the EXO|E protocol supports barrier restoration, reduces inflammation, and sustains the regenerative signal during recovery.

4. PRP as post-device

PRP works particularly well following treatments that generate a wound response, including fractional laser and RF microneedling.

Applying Cellenis PRP after these procedures introduces growth factors at the point when the skin’s repair mechanisms are most active, supporting collagen formation and reducing downtime.

The same principle applies in hair restoration, where Cellenis PRP is regularly combined with scalp-focused device treatment.

Practical Considerations for Clinics

Consent and contraindications: Biologic treatments involving blood draw require practitioners to be appropriately trained, with full medical history review, contraindication screening, and written consent in place. Key contraindications for PRP include active blood or platelet disorders, anticoagulant therapy, active infection, and immunocompromised status. Always refer to manufacturer guidance for each product.

Storage and handling: EXO|E products require temperature-controlled storage conditions. PRP must be processed and used within specified timeframes once prepared. These are not optional steps; they affect both patient safety and treatment outcomes and should be embedded in your clinic SOPs from the outset.

Staff training: Understanding the technical preparation of a biologic treatment is only part of what practitioners need. Explaining the treatment clearly, managing patient expectations, and handling post-treatment queries consistently are equally important for retention and reputation. AMP provides training and protocol support as part of its partnership with clinics, not as an add-on.

Setting patient expectations: Regenerative treatments typically require two or more sessions before optimal results are visible. Clinics that package and communicate this clearly retain patients. Clinics that imply faster or more dramatic outcomes lose them. Accurate expectation management is both a clinical responsibility and a commercial one.

Always consult appropriate clinical guidance and manufacturer protocols when designing regenerative treatment pathways. Practitioners should assess individual patient suitability before recommending any procedure.

Building a Regenerative Offering That Delivers

Regenerative aesthetics is a genuinely exciting area, but its clinical credibility depends on the choices clinics make: which products they select, how they combine them, and how clearly they communicate what patients can expect.

Plant-derived extracellular nanoparticles, PRP, and autologous biofiller each bring distinct mechanisms and benefits. Used thoughtfully alongside energy-based devices, they can meaningfully improve outcomes rather than simply adding cost to a protocol.

The clinics that will build lasting reputations in this space are those that prioritise evidence, consistency, and honest patient conversations over trend-chasing. The technology is there. The differentiation lies in how well you apply it.

The post Regenerative Aesthetics for Clinics: Exosomes, PRP & Devices appeared first on Aesthetic Medical Partnership.

Not because the technology is ineffective, but because patients use “tightening” as a catch-all phrase for a wide range of concerns.

One person means laxity and definition. Another means crepey texture. Another means dullness, pores, or “my skin just looks older”. For clinic owners, that matters. If your device choice only suits one version of “tightening”, you either end up forcing consultations into the wrong pathway or turning away good-fit patients.

The most profitable tightening strategies don’t rely on a single hero modality; they build a menu that reflects patient expectations, downtime preferences, and your clinic’s commercial model.

Below, we’ll look at the three most common technology routes clinics compare: RF, plasma-based approaches, and fractional laser, and how to consider them when you’re choosing equipment.

What “Professional Skin Tightening” Actually Means in a Clinic Context

In clinic terms, tightening isn’t a single appointment. It’s a controlled remodelling process.

Most professional technologies aim to create some combination of:

• Immediate fibre contraction (early “snap-back”)
• Collagen remodelling over weeks (the real change)
• Skin quality improvement (texture, tone, pores, fine lines)
• Structural support (where deeper layers matter)

So the decision isn’t “What’s the best technology?”

It’s:

Which layer are we treating, what’s the patient’s downtime tolerance, and how does this fit your pricing + utilisation plan?

Why Clinics Get Skin Tightening Results Wrong (even with Good Devices)

The majority of unsatisfactory tightening results are driven by mismatched patient selection and mismatched messaging, not “bad technology”. If the patient wants visible texture refinement but you deliver a primarily structural remodelling plan, they can feel let down right away.

If the patient expects a lift-like change from a skin-quality pathway, they may conclude “it didn’t work” before the remodelling phase has had time to do its job.

Your consultation process should divide “tightening” into two categories: structure-related concerns (definition and laxity) and skin-quality concerns (texture, tone, and surface ageing).

When you structure your treatment menu around those categories, it becomes far easier to recommend the right modality confidently, and to package treatment plans in a way that drives utilisation rather than one-off appointments.

Discover Our Skin Tightening Devices

RF vs Plasma vs Fractional Laser: What Each Modality is Typically Best At

RF Skin Tightening: When Laxity is the Headline

RF is often your first shortlist when the complaint is softening, loss of definition, and “I want lift”.

InLift with ThermaDAS Endolifting is designed for targeted dermal or subdermal (beneath the skin) heating delivered via a micro-cannula (tiny hollow tube) approach. It focuses on firming and remodelling in areas where structure and definition matter most.

Typically strongest for:

• Jawline softening and lower-face definition
• Midface support and patterns of sagging around the mouth
• Clients seeking a premium tightening pathway without a surgical route

Commercial angle: higher-ticket tightening consults that convert well when laxity is the primary concern.

Discover InLift with ThermaDAS Endolifting

Plasma-Based Tightening: When “Tightening” Really Means Regeneration + Refinement

Plasma shines when your typical patient is mainly focused on improved skin quality.

More even texture. Fresher tone. That slightly crepey look improving over time.

A system that gives your team protocol flexibility is often the winner here.

Jovena® combines Fractional Plasma® with RF DiatermoContraction® via FACESTIM for non-invasive facial tone support, allowing you to build layered plans based on indication and downtime appetite.

Typically strongest for:

• Complete skin regeneration (dermal remodelling, epidermal resurfacing and muscle restoration).
• Clinics wanting year-round protocols (not just one seasonal treatment)
• Treatment journey building (phased improvement rather than a one-off)

Commercial angle: great for packages and retention because it supports multiple concerns and patient types.

Discover the Jovena Device

Fractional Laser Skin Tightening: When Texture + Surface Change Drives the “Tightening” Perception

Fractional laser enters the conversation when tightening is being asked for… but the real driver is:

Fine lines. Pores. Scarring. Sun damage. Pigment. Texture. Age-related concerns.

MultiFrax™ is a portable, dual-wavelength non-ablative fractional laser (1550nm / 1927nm) designed to target broad rejuvenation indications, including texture, stretch marks, pigment-led ageing, fine lines, pores, and scarring.

Typically strongest for:

• Texture-driven rejuvenation plans where resurfacing is the hero
• Acne scarring and visible ageing patterns alongside firmness
• Clinics wanting a clear “before/after” story grounded in skin quality change

Commercial angle: strong demand for a range of sessions, with visible gains that support premium pricing.

Discover MultiFrax

Downtime and Expectation-Setting: the Quiet Driver of Five-Star Reviews

Downtime isn’t only about how red someone looks walking out of the clinic. It’s about how you build trust in the consultation and how you position results responsibly.

Some patients will gladly accept visible post-treatment signs if they believe the trade-off is a significant skin-quality change. Others will only commit if they can return to work and social plans without question.

The most effective tightening pathways are presented as a journey with a timeline. Clinics that convey “you’ll see early changes, but remodelling builds over the following weeks” typically have higher satisfaction rates, because they’ve matched expectation to biology. It also protects your team from the most common post-treatment objection: “I expected it to be instant.”

From a business perspective, your downtime positioning directly impacts your diary. Lower-disruption treatments support steady weekly utilisation, while higher-impact pathways can be premium-priced and packaged as transformations. Both can be profitable, but only if the messaging is clear.

Operational Factors that Affect ROI More than the Spec Sheet

Clinic owners often evaluate devices by headline claims and clinical outcomes, but ROI is usually determined by operational realities.

Training matters because it affects how quickly your team can deliver consistent treatments, how confidently they handle consultations, and how well they manage patient expectations.

Protocols are important as they determine whether the device is a “sometimes” purchase or a weekly workhorse. The more your team can follow a consistent pathway (consult → plan → treatment → review → maintenance), the more predictable your utilisation becomes.

Consumables, servicing, and downtime planning matter because they influence true cost-per-treatment and diary efficiency.

When purchasing a device from us, we provide comprehensive training and support to ensure your team can maximise utilisation, patient satisfaction, and revenue as soon as possible.

Book a Consultation

Closing Thought: Choose the Modality that Fits your Clinic

The RF vs plasma vs fractional laser debate only becomes confusing when it’s framed as a winner-takes-all comparison. In practice, each modality can be the “best” choice depending on whether the patient is structure-led, skin-quality-led, or looking for a blended journey.

If you want AMP UK to help you shortlist the most sensible route, the quickest way is to map your patient demand and downtime tolerance first, then match technology to the lane it will actually serve in your clinic.

Get in touch with us for more information. We will be happy to help!

Book a Consultation

The post The Clinic Owner’s Guide to Skin Tightening Technology appeared first on Aesthetic Medical Partnership.

The interview covers the technology behind both systems, including how plant-derived extracellular nanoparticles deliver cellular signals that support tissue repair, recovery and long-term skin health. Dr King and Miss Balaratnam also discuss how EXO|E and DE|RIVE fit alongside treatments many clinics already offer, including PRP and device-based procedures, and why combining regenerative protocols with existing workflows can lead to more consistent patient outcomes.

Topics covered include treatment protocols, managing patient expectations, and the direction regenerative aesthetics is heading within modern clinic settings. For practitioners looking to integrate exosome technology into their treatment plans or build longer-term strategies around regenerative skin and scalp care, this is one to watch.

Find out how plant-derived exosome technology and PRP fit into modern aesthetic practice.

The post Regenerative Aesthetics in Practice | Dr Rob King & Miss Sherina Balaratnam appeared first on Aesthetic Medical Partnership.

The post Case Study: Authentic Aesthetics Integrating Jovena into a Modern Aesthetic Clinic appeared first on Aesthetic Medical Partnership.